Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus
Authors:
- 1 October 2007
- journal article
- case report
- Published by Springer Nature in Pediatric Nephrology
- Vol. 22 (10) , 1787-1791
Abstract
Membranoproliferative glomerulonephritis, albeit uncommon, is associated with considerable morbidity and mortality in children. Corticosteroids are the mainstay of therapy for severe disease, although data supporting their use are limited. We report our experience in treating two children with nephrotic–nephritic syndrome from idiopathic membranoproliferative glomerulonephritis. Both children experienced a suboptimal response to prolonged courses of steroids and were started on tacrolimus as a steroid-sparing agent. Rapid and complete remission was achieved in both children after initiation of tacrolimus. The purpose of our report is to increase awareness of health care professionals to the potential benefits of this agent in inducing remission in children with severe membranoproliferative glomerulonephritis.Keywords
This publication has 20 references indexed in Scilit:
- FK506 in the treatment of children with nephrotic syndrome of different pathological typesClinical Nephrology, 2006
- Recurrent Glomerular Diseases After Renal TransplantationTransplantation Proceedings, 2006
- Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroidsNephrology Dialysis Transplantation, 2004
- Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritisNephrology Dialysis Transplantation, 2004
- Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantationPediatric Nephrology, 2002
- Management of membranoproliferative glomerulonephritis: Evidence-based recommendationsKidney International, 1999
- One-center experience with cyclosporine in refractory nephrotic syndrome in childrenPediatric Nephrology, 1999
- Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapyPediatric Nephrology, 1995
- Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone —a report of The International Study of Kidney Disease in ChildrenPediatric Nephrology, 1992
- Is Membranoproliferative Glomerulonephritís Really Decreasing?Nephron, 1985